Commentary
The Food and Drug Administration’s recently convened expert panel on talc may not generate headlines like a new vaccine or breakthrough cancer drug, but it deserves the full attention of every American who cares about science, transparency, and personal freedom. Despite what critics might claim about supposed “cuts” to scientific research under the Trump administration, what we are seeing now with the FDA’s talc inquiry is how government should approach health policy: identify a potential concern, gather credible experts, and evaluate the evidence deliberately before acting.